Group 1 - Broadcom's stock fell 8.4% after the company warned of reduced future margins on AI system sales, despite projecting strong quarterly revenue, raising concerns about the profitability of AI investments [1][10] - Other chip stocks, including Advanced Micro Devices, experienced a decline of 1%, while a broader chips index fell by 1.5% following Oracle's weak forecast [2][10] - Nvidia's stock increased by 0.3% as the company is considering raising H200 chip production to meet strong demand from China [11] Group 2 - The S&P 500, Dow, and Russell 2000 closed at record highs, supported by a less hawkish outlook from the Federal Reserve and a reduction in borrowing costs [5][11] - A shift towards value stocks is evident, with the Russell 2000 outperforming the S&P 500 as investors move away from AI-driven growth stocks to sectors like healthcare [6][11] - Lululemon Athletica's stock surged by 12% after the company raised its annual profit forecast and announced the departure of CEO Calvin McDonald [11] Group 3 - Cannabis companies saw significant stock increases, with Canopy Growth rising by 23% and Tilray Brands climbing by 30% following reports of potential easing of marijuana restrictions by President Trump [9][11] - Advancing issues outnumbered decliners on both the NYSE and Nasdaq, indicating a positive market sentiment [9][11] - The S&P 500 recorded 24 new 52-week highs and one new low, while the Nasdaq Composite noted 66 new highs and 37 new lows, reflecting a mixed performance in the market [9][11]

Core Insights - The reclassification of the drug is expected to alleviate tax burdens on cannabis companies [1] Industry Impact - Cannabis companies will benefit from reduced tax liabilities due to the reclassification of the drug [1]

The stock prices of major cannabis companies like Tilray Brands (NASDAQ:TLRY) and Canopy Growth (NASDAQ:CGC) skyrocketed 34.88% and 27.46%, respectively, in premarket trading on Friday, following reports of President Donald Trump‘s plans to relax federal regulations on marijuana. Meanwhile, Aurora Cannabis Inc. (NASDAQ:ACB) surged 20%, Cronos Group Inc. (NASDAQ:CRON) gained 19% and Organigram Global Inc. (NASDAQ:OGI), and SNDL Inc. (NASDAQ:SNDL) rose 12% and 34.7% respectively. Reclassification Of Cannabis ...

Group 1 - Cannabis stocks experienced significant gains, with Tilray Brands surging over 28% and Canopy Growth jumping 23% in premarket trading [1] - Innovative Industrial Properties, a cannabis facility operator, also saw an increase of more than 6% [1] - The surge in cannabis stocks was attributed to reports of President Donald Trump planning to ease federal restrictions on marijuana [1] Group 2 - Trump is expected to instruct agencies to reclassify marijuana as a Schedule III drug, which would alter tax regulations for cannabis companies and promote investment [2] - The reclassification would move marijuana from a category that includes heroin to a lower tier with less dangerous drugs, such as steroids and Tylenol with codeine, and is anticipated to occur early next year [2] - This change in classification was previously suggested by Trump in August, highlighting ongoing discussions about marijuana's legal status [3] Group 3 - Despite broader acceptance of cannabis, pot stocks have faced challenges since many went public approximately seven years ago, with Tilray shares down 36% prior to the recent surge [3]

Core Points - Decibel Cannabis Company Inc. held its annual and special meeting of shareholders on December 11, 2025, where all matters submitted for consideration were approved [1][2] Meeting Results - The number of directors elected at the meeting was fixed at four, with Shawn Dym, Nadia Vattovaz, Jakob Ripshtein, and Benjamin Sze elected as directors [8] - MNP LLP was appointed as the Company's auditors, with their remuneration to be fixed by the board of directors [8] - The 2025 Stock Option Plan was reapproved as detailed in the management information circular and proxy statement dated October 30, 2025 [8] - Shareholders authorized the Company to consolidate all issued and outstanding common shares on a basis of up to fifty pre-consolidation shares to one post-consolidation share, with the specific ratio to be determined by the board [8] Company Structure - Following the meeting, Shawn Dym, Nadia Vattovaz, and Jakob Ripshtein were appointed to serve on the Corporation's committees, with Vattovaz as chair of the Audit Committee and Ripshtein as chair of the Governance, Compensation, and Nominating Committee [4] Company Overview - Decibel is a consumer-focused cannabis company committed to innovation and product quality, with leading brands such as General Admission, Qwest, and Vox [5] - The Company operates a processing and manufacturing facility in Calgary, Alberta, and two cultivation facilities in British Columbia and Saskatchewan, along with an EUGMP licensed facility in Ontario [5]

Group 1: Broadcom and AI Trade - Broadcom is facing margin concerns after a strong Q4 performance, with expectations of a 100 basis points sequential decline in Q1 gross margin due to increased AI revenue share [4] - The company has a significant backlog of $73 billion in AI product orders scheduled over the next six quarters, but this includes lower-margin system sales [5] - Broadcom's market capitalization has surpassed that of Meta and Tesla, highlighting its importance in the AI sector following a 78% year-to-date rally [3] Group 2: Cannabis Industry - Cannabis producer stocks are rising on reports that President Trump may advocate for reclassifying marijuana from Schedule I to Schedule III, which would recognize its medical applications [6][7] - A call was held involving Trump and several cannabis industry executives to discuss the reclassification proposal, although no final decision has been made [7] Group 3: Anheuser-Busch InBev - Anheuser-Busch InBev plans to close its Merrimack, N.H. brewery by early 2026 as part of a modernization effort, aligning with closures at other sites [8][9] - The company holds a leading position in the U.S. beer market with approximately 33% market share, with Michelob Ultra being the top-selling beer by volume [10]

Group 1: Broadcom and AI Trade - Broadcom is facing margin concerns after a strong Q4 performance, with expectations of a 100 basis points sequential decline in Q1 gross margin due to increased AI revenue share [4] - The company has a significant backlog of $73 billion in AI product orders scheduled over the next six quarters, but this includes lower-margin system sales [5] - Broadcom's market capitalization has surpassed that of Meta and Tesla, highlighting its importance in the AI sector [3] Group 2: Cannabis Industry - Cannabis producer stocks are rising on reports that President Trump may advocate for reclassifying marijuana from Schedule I to Schedule III, which would recognize its medical applications [6][7] - A call was held involving Trump and several cannabis industry executives to discuss the reclassification proposal, although no final decision has been made [7] Group 3: Anheuser-Busch InBev - Anheuser-Busch InBev plans to close its Merrimack, N.H. brewery by early 2026 as part of a modernization effort, aligning with closures at other sites [8][9] - The company holds a leading position in the U.S. beer market with approximately 33% market share, with Michelob Ultra being the top-selling beer by volume [10]

Multiple reports say President Trump is preparing to order his administration to reclassify marijuana as a less dangerous drug. A Washington Post report said Trump held a meeting at the White House on Wednesday with marijuana industry executives along with HHS Secretary Robert F. Kennedy Jr.. and CMS administrator Dr. . Memed Oz. They were joined on the phone by Speaker Mike Johnson who cited studies arguing against the move.The executives reportedly rebutted Speaker Johnson's arguments and Trump left the c ...

Core Viewpoint - Shares of cannabis companies experienced a significant increase following reports that U.S. President Donald Trump is expected to advocate for substantial reductions in federal restrictions on marijuana [1] Group 1 - The Washington Post's report has led to a positive market reaction for cannabis companies, indicating investor optimism regarding potential regulatory changes [1]

Market Overview - U.S. stock futures showed mixed performance following a mixed close on Thursday, with major indices experiencing fluctuations [1] - The Dow Jones increased by over 600 points, indicating a rotation out of expensive tech stocks, while overall risk appetite remained strong after the Federal Reserve's third consecutive interest-rate cut [1] Economic Indicators - The 10-year Treasury bond yielded 4.17%, while the two-year bond was at 3.53%, with a 73.4% likelihood of the Federal Reserve maintaining current interest rates [2] Futures Performance - Dow Jones futures increased by 0.17%, while S&P 500 and Nasdaq 100 futures decreased by 0.19% and 0.54%, respectively [3] Stocks in Focus - Costco Wholesale Corp. reported better-than-expected financial results for Q1 of fiscal 2026 but saw a premarket decline of 0.52% [7] - Broadcom Inc. dropped 5.18% due to disappointing guidance regarding gross margins and a higher tax rate for fiscal 2026 [7] - Lululemon Athletica Inc. surged 9.49% after exceeding Q3 expectations and raising full-year guidance [16] - RH experienced a 4.26% increase despite mixed Q3 results, reporting earnings of $1.71 per share, missing estimates [16] - Tilray Brands Inc. rose 28.11% following the announcement of its new product line [16] Analyst Insights - Scott Wren from Wells Fargo anticipates moderate growth and easing price pressures in the U.S. economy, projecting S&P 500 earnings growth of slightly over 11% [12] - Wren recommends active management and suggests reallocating funds from Communication Services and Information Technology to sectors like Financials, Industrials, and Utilities, which are expected to benefit from AI capital expenditures [13][14]